Private Trust Company’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-151
Closed -$22K 450
2014
Q3
$22K Hold
151
0.01% 808
2014
Q2
$25K Hold
151
0.01% 770
2014
Q1
$30K Hold
151
0.01% 627
2013
Q4
$29K Buy
151
+78
+107% +$14.5K 0.01% 587
2013
Q3
$12K Buy
73
+67
+1,117% +$10.4K 0.01% 832
2013
Q2
$1K Buy
+6
New +$850 ﹤0.01% 1507

Other funds holding CLB

Private Trust Company's CLB Position: Q4 2014 in Review

Private Trust Company sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 151 shares — an estimated $22K sold.

Private Trust Company first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $30K in Q1 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • Private Trust Company reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 151 Core Laboratories shares in Q4 2014, an estimated $22K.
  • Private Trust Company first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
  • Private Trust Company's Core Laboratories position peaked at $30K in Q1 2014.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.